Company / Operating Income per Share
Aurinia Pharmaceuticals Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.74
FY2025
5-year range
-$0.82 / $0.74
FY2021-FY2025
Trend
+2385.3%
vs FY2024
Sector context
#42 of 201
Health Care
What the data says
Operating Income per Share changed +2385% YoY in FY2025, a notable deviation from the 7-year average annual change of +351%.
Based on SEC 10-K filings.
0.74 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.65 to $0.74 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 201This company $0.74 Sector average -$3.23
▼
+123.0% above sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 2385.3% year-over-year.
- Ranks #42 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.74 | +2385.3% |
| FY2024 | -$0.03 | +95.0% |
| FY2023 | -$0.65 | +21.3% |
| FY2022 | -$0.82 | -1.2% |
| FY2021 | -$0.81 | +33.3% |
| FY2020 | -$1.22 | -24.8% |
| FY2019 | -$0.98 | -50.0% |
| FY2018 | -$0.65 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026